Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare
Pacific Biosciences of California, Inc. Price to FCF Ratio 2010–2026
Price to free cash flow (P/FCF) ratio for Pacific Biosciences of California, Inc. (PACB): market cap divided by trailing twelve-month free cash flow. As of September 30, 2021 it is 297.69.
From: 06/30/2011To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Pacific Biosciences of California, Inc. Price to FCF Ratio — FAQ
Pacific Biosciences of California, Inc. (PACB) price to fcf ratio over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PACB's price to fcf ratio history?
The chart and table above show Pacific Biosciences of California, Inc.'s price to fcf ratio by year and by quarter, including the growth rate.